BRCA-P

Prevention

BRCA-P is a world-first trial that aims to prevent breast cancer in women with a BRCA1 gene mutation.

CAPTURE

Metastatic

The CAPTURE clinical trial aims to identify women and men with hormone-receptor positive metastatic breast cancer, who may benefit from a novel combination of drugs that may improve progression free…

EXPERT

Early Breast Cancer

EXPERT aims to improve personalised use of radiation therapy in early breast cancer patients by using a genomic test to identify women who can safely avoid this treatment after surgery and the…

FINER

Metastatic

The FINER clinical trial aims to find out if cancer will remain under control for longer in patients with advanced ER-positive and HER2-negative breast cancer.

OPTIMA

Early Breast Cancer

The OPTIMA trial aims to find out if using a test called Prosigna can help make safe and accurate decisions about whether or not chemotherapy treatment is needed for participants with ER-positive,…

TUGETHER

Metastatic

TUGETHER aims to treat advanced HER2-positive breast cancer that has come back or spread after anti-HER2 treatment (such as trastuzumab (Herceptin(R)), pertuzumab (Perjeta(R)) or TDM-1 (Kadcycla(R)))…

BCT Trials & Projects Summary

A reference table summarising BCT’s current open trials and funded Discretionary Funding projects.

The trial categories, populations, and phases can be filtered to allow researchers to refine areas of interest, identifying potential ideas for future BCT trials.

LEARN MORE ABOUT CLINICAL TRIALS

WHY I SUPPORT BREAST CANCER TRIALS